ClinicalTrials.gov
public full text
Public Domain
Psilocybin for Major Depressive Disorder
The goal of this study is to assess the effectiveness of psilocybin for the treatment of Major Depressive Disorder and potential therapeutic mechanisms. Enrolled participants will receive a single active dose of psilocybin, or a dose considered high enough to treat depression, administered orally with accompanying psychological support.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Psilocybin-assisted Interpersonal Therapy for Depression#1085490
- Open-Label Psilocybin Study in Transdiagnostic Population#1124679
- Psilocybin-assisted CBT for Depression#914232
- Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence#1010534
- A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder.#323217
Record · ID 1150988
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive